Abstract
Background
Acne vulgaris is a multifactorial disease of the pilosebaceous unit of human skin. Previous studies have identified an acne-associated dysbiosis of the skin microbiome.
Objectives
This dysbiosis was mainly determined for Cutibacterium acnes. However, detailed analyses combining qualitative and quantitative aspects are scarce, also regarding the possible contribution of other skin bacteria and the impact of treatment.
Methods
We conducted a culture-independent study to determine differences between the healthy skin and the acne microbiome before and after isotretinoin treatment. Three amplicon-based sequencing approaches and digital droplet PCR for quantification were applied.
Results
Our results revealed a 2.2-fold reduced abundance of C. acnes with a reduced diversity in the acne microbiome. A phylotype switch was found, which was mainly characterized by a significant relative decrease of IB and II strains in the acne microbiome. In contrast, the relative abundance of staphylococci increased significantly and the quantitative ratio of staphylococci to C. acnes strongly increased from 1:34 in the healthy cohort to 1:11 in the acne cohort. The diversity of staphylococci was reduced, mainly due to the decrease of Staphylococcus hominis, and the appearance and predominance of Staphylococcus aureus in some acne patients. Isotretinoin treatment drastically depleted C. acnes (37-fold) and moderately also staphylococci (3.6-fold). Isotretinoin treatment resulted in a decrease of Staphylococcus epidermidis and a significant increase of S. aureus on facial skin.
Conclusions
The switch from a C. acnes-dominated healthy skin microbiome towards an acne microbiome that is relatively enriched in staphylococci could indicate a stronger impact of staphylococci in the pathophysiology of acne than currently acknowledged. Our data further showed that isotretinoin largely eliminated the skin microbiome and in particular C. acnes, but also S. epidermidis. Instead, more harmful bacteria such as S. aureus could expand, suggesting that posttreatment strategies should be considered to accelerate skin microbiome recovery.
Acne vulgaris is a multifactorial disease of the pilosebaceous unit of human skin. Previous studies have identified an acne-associated dysbiosis of the skin microbiome.
Objectives
This dysbiosis was mainly determined for Cutibacterium acnes. However, detailed analyses combining qualitative and quantitative aspects are scarce, also regarding the possible contribution of other skin bacteria and the impact of treatment.
Methods
We conducted a culture-independent study to determine differences between the healthy skin and the acne microbiome before and after isotretinoin treatment. Three amplicon-based sequencing approaches and digital droplet PCR for quantification were applied.
Results
Our results revealed a 2.2-fold reduced abundance of C. acnes with a reduced diversity in the acne microbiome. A phylotype switch was found, which was mainly characterized by a significant relative decrease of IB and II strains in the acne microbiome. In contrast, the relative abundance of staphylococci increased significantly and the quantitative ratio of staphylococci to C. acnes strongly increased from 1:34 in the healthy cohort to 1:11 in the acne cohort. The diversity of staphylococci was reduced, mainly due to the decrease of Staphylococcus hominis, and the appearance and predominance of Staphylococcus aureus in some acne patients. Isotretinoin treatment drastically depleted C. acnes (37-fold) and moderately also staphylococci (3.6-fold). Isotretinoin treatment resulted in a decrease of Staphylococcus epidermidis and a significant increase of S. aureus on facial skin.
Conclusions
The switch from a C. acnes-dominated healthy skin microbiome towards an acne microbiome that is relatively enriched in staphylococci could indicate a stronger impact of staphylococci in the pathophysiology of acne than currently acknowledged. Our data further showed that isotretinoin largely eliminated the skin microbiome and in particular C. acnes, but also S. epidermidis. Instead, more harmful bacteria such as S. aureus could expand, suggesting that posttreatment strategies should be considered to accelerate skin microbiome recovery.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | JEADV Clinical Practice |
| Vol/bind | 3 |
| Udgave nummer | 5 |
| Sider (fra-til) | 1454-1466 |
| Antal sider | 13 |
| DOI | |
| Status | Udgivet - dec. 2024 |
Bibliografisk note
Publisher Copyright:© 2024 The Author(s). JEADV Clinical Practice published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology.